Japanese researchers used a nonviral piggyBac system to genetically modify cynomolgus monkeys, enabling more accurate disease ...

Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death of a patient taking Sarepta’s Elevidys raises important safety questions.

DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...

Researchers at City of Hope have found that cell mutations are necessary but not always sufficient for tumors to form.

Researchers at University of Tsukuba have developed "tomoseqr"—a new software tool that enables easy estimation of the ...

Genetic engineering in non-human primates has historically faced limitations due to the reliance on virus-based gene delivery methods.

A recent study has shed light on the transcriptional regulatory mechanisms of Penicillium expansum, the fungal culprit behind ...

WVE-N531, an oligonucleotide, elicited significant functional benefit and reversal of muscle damage in the Phase II ...